Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-823-7 | CAS number: 74-94-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Direct observations: clinical cases, poisoning incidents and other
Administrative data
- Endpoint:
- direct observations: clinical cases, poisoning incidents and other
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- publication
- Title:
- Case Report: the Clinical Toxicity of Dimethylamine Borane
- Author:
- Tsan Y. et al.
- Year:
- 2 005
- Bibliographic source:
- Environ Health Perspect. 2005 Dec; 113(12): 1784–1786
Materials and methods
- Study type:
- poisoning incident
- Endpoint addressed:
- neurotoxicity
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- A case were reported of a man who suffered from work-related exposure to DMAB.
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Dimethylamine-borane (1:1)
- EC Number:
- 200-823-7
- EC Name:
- Dimethylamine-borane (1:1)
- Cas Number:
- 74-94-2
- Molecular formula:
- C2H10BN
- IUPAC Name:
- N-Methylmethanamine-borane (1:1)
Constituent 1
Method
- Type of population:
- occupational
- Subjects:
- - Number of subjects exposed: 1
- Sex: male
- Age: 36
- Race: no data
- Demographic information: no data
- Known diseases: no data - Ethical approval:
- not specified
- Route of exposure:
- dermal
- Reason of exposure:
- accidental
- Exposure assessment:
- not specified
- Details on exposure:
- A 36-year-old, healthy male was accidentally sprayed over the face and trunk with the liquid form of DMAB. He kept on working and did not take a shower until > 1 hr later. The DMAB which the worker were exposed was a liquid sprayed on the patient containing 97% DMAB and 3% decomposed materials including boric acid, borates, hydrogen, dimethylamine. DMAB was the only toxic substance at the workplace.
- Examinations:
- - blood cell count, electrolytes, blood sugar, hepatic and renal function tests, clinical signs, brain computerized tomogram, physical examinations, urinalysis
- Medical treatment:
- not specified
Results and discussion
- Clinical signs:
- The patient developed dizziness, nausea, vomiting, sore throat, limb numbness, slurred speech, slow motion, lack of concentration, and ataxia by the next morning, 13 hr after exposure. He was admitted to a local hospital, where a normal brain computerized tomogram was noted. Because of worsening clinical conditions, including “masked” face, irritability, awkwardness, and rocking from side to side while sitting on the bed, he was transferred to our hospital 3 days later. Physical examination revealed some
abnormal neurologic findings. The patient was oriented as to time and place but was easily distracted. His speech was slurred. Normal muscle power was noted for all four limbs. He could stand on a wide base with assistance but deviated to both sides when attempting a tandem gait. Impairment on finger-tonose and heel-to-knee tests was also noted. - Results of examinations:
- Mild hyperventilation, with arterial blood gas of pH 7.510, partial pressure of carbon dioxide 30.6 mm Hg, partial pressure of oxygen 100 mm Hg, and bicarbonate 24.7 mmol/L, was found. No drug history, including use of herbal medicine, was noted for the last 3 months. Urinalysis did not detect any illegal drugs, central nervous system-acting drugs, or other medications. Normal blood and urine lead, mercury, and aluminium levels were also noted.
Eight days after chemical exposure, the patient’s electroencephalogram (EEG) revealed diffuse background slowing, indicative of a mild diffuse cerebral dysfunction. Tests of nerve conduction velocity (NCV) for the left-side limbs were normal. Brain magnetic resonance imaging (MRI) on the eighth day showed a symmetric increase in signal intensity on FLAIR (fluid-attenuated inversion recovery), T2WI (T2-weighted intensity), and DWI (diffusion weighted images), but low signal intensity on T1WI without postcontrast enhancement at bilateral cerebellar periventricular areas. A steroid was prescribed for treatment of the possible acute inflammatory effects on neurons. The patient was discharged with stable neurologic function after 6 days of observation. - Outcome of incidence:
- The patient was readmitted to the neurology outpatient clinic 18 days after chemical exposure due to difficulty in walking and climbing. Physical examination revealed that the deep tendon reflexes of both knees were areflexic. Muscle power was mildly decreased in the distal and proximal parts of the upper right leg. Lower leg weakness and drop foot were also found bilaterally with muscle power of grade 2/5 in the right foot and 3/5 in the left foot. A nerve conduction study on the 29th day after poisoning showed decreased NCV and complex muscular action potential (CMAP) amplitudes for the left median, left ulnar, left peroneal, and left tibial nerves. H-reflex was absent bilaterally. Sensory conduction and sensory evoked potential tests of the nerves of the upper left and lower left limbs were normal. A brain MRI on the 37th day after poisoning showed that the previous lesions in the cerebellar
dentate nuclei region had subsided. With active physical therapy, the patient could walk straight on a wide base 2 months after poisoning. No dysmetria was noted on the finger-to-nose test, but heel or toe gait was impaired. The muscle power was grade 3/5 in the flexor and extensor of the right foot; 4/5 in the flexor and extensor of the left foot, and others were all 5/5. Weakness in the flexor and extensor of both feet still remained. A repeat EEG was normal. A repeat NCV study revealed no change in polyneuropathy with motor predominant axonal degeneration. The patient receives regular outpatient follow ups. He still walks with a clumsy gait and has difficulty with hand-grasping activity.
Any other information on results incl. tables
Other information about the patient:
The patient denied any medical problems such as hypertension, diabetes, and neurologic diseases. He smoked one pack of cigarettes per day and drank alcohol occasionally.
Applicant's summary and conclusion
- Conclusions:
- This case study reported that DMAB is toxic to humans and causes neurotoxicity as polyneuropahthy with motor-predominant axonal degeneration at high concentrations.
- Executive summary:
In this case report, a 36 -year-old, healthy male was accidentally sprayed over the face and trunk with the liquid form of Dimethylamine borane (DMAB). The patient did not decontaminate at once, and he suffered from more severe symptoms, including dizziness, nausea, limb numbness, slurred speech, irritable mood, and ataxia 13 hr later. Magnetic resonance imaging showed symmetric lesions with hyperintensity on T2WI and FLAIR in bilateral cerebellar dantate nuclei. This patient was readmitted to the hospital due to difficulty in walking and climbing 18 days after exposure. Lower leg weakness and drop foot were found bilaterally. A nerve conduction study revealed polyneuropathy with motor-predominant axonal degeneration. This patient receives regular outpatient follow ups and still walks with a clumsy gait and has difficulty with hand-grasping activity. This case study demonstrates that DMAB is neurotoxic to humans at high concentrations.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.